Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annovis Bio Inc
(NY:
ANVS
)
13.60
+0.86 (+6.75%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
330,431
Open
12.55
Bid (Size)
12.80 (1)
Ask (Size)
13.66 (1)
Prev. Close
12.74
Today's Range
12.55 - 13.64
52wk Range
5.420 - 22.49
Shares Outstanding
11,011,299
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
April 02, 2024
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
April 02, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
Performance
YTD
-28.16%
-28.16%
1 Month
+15.45%
+15.45%
3 Month
+48.80%
+48.80%
6 Month
+63.66%
+63.66%
1 Year
-8.48%
-8.48%
More News
Read More
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 20, 2024
Via
Benzinga
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
March 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
March 06, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
3 Growth Stocks to Sell in February Before They Bottom
February 12, 2024
Via
InvestorPlace
Dow Edges Lower; US Composite PMI Rises In January
January 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
Crude Oil Rises Over 1%; DuPont Shares Plunge
January 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Annovis Bio (ANVS) Stock Is Getting Hammered
January 24, 2024
Via
Benzinga
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
January 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
Via
Benzinga
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
December 04, 2023
Via
MarketBeat
Topics
Bonds
Exposures
Debt Markets
Annovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s Patients
November 02, 2023
From
Annovis Bio
Via
Business Wire
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Annovis Bio (ANVS) Stock Hit A New 52-Week Low Today
October 31, 2023
Via
Benzinga
Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
October 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 31, 2023
Via
Benzinga
Annovis Bio Announces Pricing of $7.5 Million Public Offering
October 31, 2023
From
Annovis Bio, Inc.
Via
Business Wire
Annovis Bio Announces Launch of Proposed Public Offering
October 30, 2023
From
Annovis Bio, Inc.
Via
Business Wire
Annovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)
October 30, 2023
From
Annovis Bio, Inc.
Via
Business Wire
Annovis Bio Showcases Promising Progress in Novel Drug Development at the 2023 Clinical Trials on Alzheimer's Disease Conference
October 24, 2023
From
Annovis Bio, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.